ocriplasmin
Showing 1 - 21 of 21
Vitreomacular Traction, Subretinal Edema Trial in Norfolk (Eplerenone)
Terminated
- Vitreomacular Traction
- Subretinal Edema
-
Norfolk, VirginiaWagner Macula & Retina Center
Jan 6, 2021
Diabetic Retinopathy, Posterior Vitreous Detachment, Disease Progression Trial in Worldwide (ocriplasmin 0.0625mg, ocriplasmin
Terminated
- Diabetic Retinopathy
- +2 more
- ocriplasmin 0.0625mg
- +2 more
-
Phoenix, Arizona
- +37 more
Dec 8, 2020
Vitreomacular Traction, Vitreomacular Adhesion Trial in New South Wales (Ocriplasmin 0.125 mg in a 0.1 mL volume)
Completed
- Vitreomacular Traction
- Vitreomacular Adhesion
- Ocriplasmin 0.125 mg in a 0.1 mL volume
-
New South Wales, AustraliaContact Alcon Laboratories (Australia) for Trial Locations
Jul 23, 2018
Central Retinal Vein Occlusion Trial in Leuven (Ocriplasmin intravenously)
Completed
- Central Retinal Vein Occlusion
- Ocriplasmin intravenously
-
Leuven, Vlaams Brabant, BelgiumUZ Leuven
Jan 4, 2018
Vitreomacular Traction Syndrome Trial in Split (Pneumatic Vitreolysis in combination with "Drinking-Bird-Technique")
Unknown status
- Vitreomacular Traction Syndrome
- Pneumatic Vitreolysis in combination with "Drinking-Bird-Technique"
-
Split, CroatiaUniversity Hospital of Split, Department of Ophthalmology
May 31, 2019
Assess Visual Function in Subset of Previously Participated in
Completed
- Symptomatic Vitreomacular Adhesion
- ocriplasmin
- placebo
-
Houston, Texas
- +1 more
Jan 12, 2017
Vitreomacular Traction, Vitreomacular Adhesion Trial (Ocriplasmin)
Completed
- Vitreomacular Traction
- Vitreomacular Adhesion
- Ocriplasmin
- (no location specified)
Aug 19, 2016
Vitreomacular Adhesion Including Macular Hole Trial in United States (Ocriplasmin, Sham injection)
Completed
- Vitreomacular Adhesion Including Macular Hole
- Ocriplasmin
- Sham injection
-
Phoenix, Arizona
- +24 more
Feb 18, 2016
Symptomatic Vitreomacular Adhesion Trial in Tokyo (Ocriplasmin, Sham injection)
Completed
- Symptomatic Vitreomacular Adhesion
- Ocriplasmin
- Sham injection
-
Tokyo, JapanContact Alcon for Trial Locations
Nov 2, 2015
Symptomatic Vitreomacular Adhesion Trial in United States
Completed
- Symptomatic Vitreomacular Adhesion
-
Phoenix, Arizona
- +109 more
Jun 20, 2016
Patients Treated With Ocriplasmin for Symptomatic VMA
Completed
- Symptomatic Vitreomacular Adhesion (VMA)
-
Campbell, California
- +23 more
Jul 8, 2015
Vitreomacular Adhesion Trial in Mountain View (Intravitreal Injection of sulfahexafluoride gas)
Withdrawn
- Vitreomacular Adhesion
- Intravitreal Injection of sulfahexafluoride gas
-
Mountain View, CaliforniaNorthern California Retina Vitreous Associates
Jan 30, 2016
Vitreopapillary Interface and Optic Disc Morphology
Unknown status
- Posterior Vitreous Detachment
- +3 more
- OCT imaging/HRT imaging
-
Leuven, BelgiumUniversity Hospitals Leuven
Jan 20, 2016
Vitreomacular Traction Trial in Belgium, Germany (ocriplasmin, Sham Comparator)
Completed
- Vitreomacular Traction
- ocriplasmin
- Sham Comparator
-
Antwerpen, Belgium
- +3 more
Dec 2, 2014
Exudative Age-Related Macular Degeneration, Focal Vitreomacular Adhesion Trial in Worldwide (Ocriplasmin, Sham injection)
Completed
- Exudative Age-Related Macular Degeneration
- Focal Vitreomacular Adhesion
- Ocriplasmin
- Sham injection
-
Beverly Hills, California
- +26 more
Dec 2, 2014
Vitrectomy Trial in Royal Oak, (Ocriplasmin, Placebo)
Completed
- Vitrectomy
- Ocriplasmin
- Placebo
-
Royal Oak,, MichiganAssociated Retina Consultants
Dec 2, 2014
Diabetic Macular Edema Trial in Worldwide (ocriplasmin, Sham injection)
Completed
- Diabetic Macular Edema
- ocriplasmin
- Sham injection
-
Antwerpen, Belgium
- +14 more
Dec 2, 2014
Vitreomacular Adhesion Trial in United States (125 µg Ocriplasmin, Placebo)
Completed
- Vitreomacular Adhesion
- 125 µg Ocriplasmin
- Placebo
-
Phoenix, Arizona
- +40 more
Dec 2, 2014
Vitreomacular Adhesion Trial in Worldwide (Ocriplasmin 125µg, Placebo)
Completed
- Vitreomacular Adhesion
- Ocriplasmin 125µg
- Placebo
-
Campbell, California
- +47 more
Dec 2, 2014